Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing

Farzaneh Foroughinia1, Mahtabalsadat Mirjalili1

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Low vitamin D levels are linked to higher matrix metalloproteinase-9 (MMP-9) in patients after percutaneous coronary intervention (PCI). This suggests vitamin D deficiency may increase cardiovascular disease risk by affecting atherosclerotic plaques.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Cardiovascular diseases (CVD) are a growing global health threat.
  • Matrix metalloproteinase-9 (MMP-9) is implicated in atherosclerosis and cardiac remodeling.
  • Vitamin D deficiency is an emerging risk factor for cardiovascular diseases.

Purpose of the Study:

  • To investigate the association between vitamin D status and MMP-9 levels in Iranian patients.
  • To assess the relationship between vitamin D levels and MMP-9 in patients undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • Prospective cross-sectional study involving 150 patients scheduled for elective coronary angioplasty.
  • Measurement of baseline serum MMP-9 and 25(OH) vitamin D levels.
  • Categorization of patients based on vitamin D levels: severely deficient (≤10 ng/mL), moderately deficient (11-20 ng/mL), and insufficient/sufficient (>21 ng/mL).

Main Results:

  • Serum MMP-9 levels were significantly higher in patients with lower vitamin D concentrations.
  • A significant inverse correlation was observed between MMP-9 concentration and 25(OH) vitamin D levels (P = 0.039).
  • Higher MMP-9 levels were associated with lower vitamin D status in the study population.

Conclusions:

  • Low vitamin D levels may contribute to more vulnerable atherosclerotic plaques in post-PCI patients.
  • Vitamin D status is inversely correlated with MMP-9 levels, suggesting a potential role in cardiovascular adverse effects.
  • Findings highlight the importance of assessing vitamin D status in patients undergoing PCI.

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
313
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
197
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
74
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
503